The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gudkova V.V.

Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova, Moskva

Stakhovskaya L.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Shanina T.V.

NII tserebrovaskuliarnoĭ patologii i insul'ta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Meshkova K.S.

Kafedra fundamental'noĭ i klinicheskoĭ nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova

Shekhovtsova K.V.

NII tserebrovaskuliarnoĭ patologii i insul'ta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Authors:

Gudkova V.V., Stakhovskaya L.V., Shanina T.V., Meshkova K.S., Shekhovtsova K.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11): 87‑94

Read: 1448 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Gudkova VV, Stakhovskaya LV, Shanina TV, Meshkova KS, Shekhovtsova KV. . S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11):87‑94. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Factors dete­rmining the effe­ctiveness of various anti­thrombotic therapy regi­mens after coro­nary artery bypass surgery in patients with diffuse lesions and small diameter of coro­nary arte­ries: a 12-month prospective follow-up. Russian Cardiology Bulletin. 2025;(3):25-35
Abstract:

Authors:

Gudkova V.V.

Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova, Moskva

Stakhovskaya L.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Shanina T.V.

NII tserebrovaskuliarnoĭ patologii i insul'ta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Meshkova K.S.

Kafedra fundamental'noĭ i klinicheskoĭ nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova

Shekhovtsova K.V.

NII tserebrovaskuliarnoĭ patologii i insul'ta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Close metadata

References:

  1. Baryshnikova G.A. Trombo-ASS - rol' i mesto v profilaktike tromboticheskikh sostoyanii. Metodicheskie rekomendatsii. M 2003; 20.
  2. Baryshnikova G.A. Dipiridamol v obshcheterapevticheskoi praktike. Problemy zhenskogo zdorov'ya 2007; 2: 1: 1-5.
  3. Belousov Yu.B. Otsenka effektivnosti i bezopasnosti dlitel'noi profilaktiki arterial'nykh trombozov. Mezhdunarodnyi med zhurn 1999; 8: 11-12.
  4. Belyavskii N.N., Likhachev S.A., Varenik T.N., Demarin V. Klinicheskie i patogeneticheskie osobennosti tranzitornykh ishemicheskikh atak v karotidnom basseine u bol'nykh molodogo i srednego vozrasta. Nevrol zhurn 2008; 4: 9-14.
  5. Bokarev I.N. Lechenie oral'nymi antikoagulyantami: Metodicheskie rekomendatsii. M: GOU VPO "MGMSU ROSZDRAVA", M: GOUVPO "MMA im. I.M. Sechenova" 2007; 48.
  6. Vorob'ev A., Ataullakhanov F., Emel'yanenko V. i dr. Analiz prostranstvennoi dinamiki svertyvaniya: novyi global'nyi test svertyvaniya krovi. Sovremennye meditsinskie tekhnologii 2010; 4: 32-37.
  7. Gusev E.I., Skvortsova V.I. Ishemiya golovnogo mozga. M: Meditsina 2001; 328.
  8. Drapkina O.M., Kostyukevich M.V. Arterial'naya gipertenziya: ot fibrillyatsii predserdii i insul'ta do metabolicheskogo sindroma. Spravochnik poliklinicheskogo vracha 2010; 8: 37-39.
  9. Dyuba D.Sh., Evtushenko S.K., Rodin Yu.V., Fedorova A.A. Sostoyanie antioksidantnoi sistemy i perekisnogo okisleniya lipidov u bol'nykh, perenesshikh karotidnuyu endarterektomiyu, v techenie pervykh semi sutok pod vliyaniem tseraksona. Mezhdunarodnyi nevrologicheskii zhurnal 2010; 4: 34: 21-23.
  10. Zagidullin N.Sh., Zagidullin Sh.Z. Osobennosti lecheniya bol'nykh, perenesshikh insul't, v terapevticheskoi praktike. Spravochnik poliklinicheskogo vracha 2010; 8: 29-32.
  11. Khenneritsi M.G., Boguslavski Zh., Sakko R.L. Insul't: Klinicheskoe rukovodstvo. Per. s angl. Pod obshch. red. chl.-korr. RAMN Skvortsovoi V.I. 2-e izd. M: MEDpress-inform 2008; 224.
  12. Kozlova T.V., Taratuta T.V., Aksenova M.B., Khlevchuk T.V. Vzaimodeistvie al'ternativnoi terapii s varfarinom: chto neobkhodimo znat' vracham. Kardiovask ter i prof 2010; 9: 3: 106-109.
  13. Mel'nikova E.V., Kadinskaya M.I., Gerasimenko D.V., Shmonin A.A. Antitromboticheskaya terapiya vo vtorichnoi profilaktike ishemicheskogo insul'ta. Insul't. Zhurn nevrol i psikhiat 2010; 12: 2: 23-27.
  14. Nedogoda S.V. Vozmozhnosti simvastatina v lechenii zabolevanii serdechno-sosudistoi sistemy. Spravochnik poliklinicheskogo vracha 2010; 8: 40-43.
  15. Panteleev M.A., Ataullakhanov F.I. Svertyvanie krovi: sovremennye problemy. Klinicheskaya onkogematologiya 2008; 1: 3: 259-265.
  16. Parfenov V., Verbitskaya S. Vtorichnaya profilaktika ishemicheskogo insul'ta: perspektivy i real'nost'. Vrach 2002; 12: 39-41.
  17. Rekomendatsii po vedeniyu bol'nykh s ishemicheskim insul'tom i tranzitornymi ishemicheskimi atakami. Evropeiskaya organizatsiya po bor'be s insul'tom. Redaktsiya 2008; 104.
  18. Skvortsova V.I., Chazova I.E., Stakhovskaya L.V. Vtorichnaya profilaktika insul'ta. M: PAGRI 2002; 118.
  19. Skvortsova V.I., Stakhovskaya L.V, Pryanikova N.A. i dr. Antiagreganty v profilaktike ishemicheskogo insul'ta: puti povysheniya effektivnosti. Consilium medicum 2006; 8: 2: 92-96.
  20. Skvortsova V.I., Stakhovskaya L.V, Pryanikova N.A. i dr. Kak pravil'no vybrat' antiagregant dlya vtorichnoi profilaktiki ishemicheskogo insul'ta. Consilium medicum 2007; 9: 2: 68-72.
  21. Skvortsova V.I., Pryanikova N.A. Issledovanie agregatsionnoi sposobnosti trombotsitov. Nevrologiya: natsional'noe rukovodstvo. Pod red. E.I. Guseva, A.N. Konovalova, V.I. Skvortsovoi, A.B. Gekht. M: GEOTAR-Media 2009; 105-116.
  22. Skvortsova V.I., Stakhovskaya L.V., Pryanikova N.A., Meshkova K.S. Vtorichnaya profilaktika insul'ta - vzglyad nevrologa. Nov strategiї v nevrologiї. Materiali XI Mizhnarodnoї konferentsiї, 26-29 kvitnya 2009 roku, m. Sudak. Pid redaktsiεyu S.M. Kuznetsovoї. Kuїv 2009; 195-200.
  23. Stakhovskaya L.V., Pryanikova N.A. Sravnitel'nyi analiz effektivnosti antiagregantnoi terapii u bol'nykh s ishemicheskim insul'tom. Spravochnik poliklinicheskogo vracha 2008; 3: 85-88.
  24. Stakhovskaya L.V. Atiagreganty: voprosy effektivnosti i bezopasnosti profilaktiki ishemicheskogo insul'ta. Mezhdunarodnyi med zhurn 1999; 5: 11-12.
  25. Skvortsova V.I., Gudkova V.V. Autoimmunnye narusheniya nervnoi sistemy. Lektsii po pediatrii. Tom 9. Immunologiya. Pod red. V.F. Demina, S.O. Klyuchnikova, I.G. Kozlova, A.P. Prodeusa. M: RGMU 2010; 232-249.
  26. Stakhovskaya L.V., Meshkova K.S., Shekhovtsova K.V., Skvortsova V.I. Differentsirovannaya vtorichnaya profilaktika insul'ta: dopolnenie k rekomendatsiyam. Consilium medicum. Pril.: Nevrologiya 2009; 1: 16-18.
  27. Suslina Z.A. (red.). Ocherki angionevrologii. M 2005; 360.
  28. Suslina Z.A., Tanashyan M.M. Antiagregantnaya terapiya pri ishemicheskikh tserebrovaskulyarnykh zabolevaniyakh. Posobie dlya praktikuyushchikh vrachei. M 2003.
  29. Suslina Z.A., Tanashyan M.M., Ionova V.G. Ishemicheskii insul't: krov', sosudistaya stenka, antitromboticheskaya terapiya. M 2005; 247.
  30. Tanashyan M.M., Umarova R.M., Geraskina L.A., Fonyakin A.V. Gemangiokorrektornaya effektivnost' Plaviksa u bol'nykh s tserebral'noi ishemiei. Atmosfera. Nervnye bolezni 2005; 3: 2-7.
  31. Tanashyan M.M., Domashenko M.A. Klopidogrel pri ishemicheskikh tserebrovaskulyarnykh zabolevaniyakh. Atmosfera. Nervnye bolezni 2007; 2: 13-16.
  32. Tul Dzh.F., Gusev E.I. Tranzitornye ishemicheskie ataki: diagnostika i lechenie. Sosudistye zabolevaniya golovnogo mozga. Per. s angl. Pod red. akad. RAMN E.I. Guseva, prof. A.B. Gekht. Rukovodstvo dlya vrachei: 6-e izd. M: GEOTAR-Media 2007; 73-102.
  33. Fonyakin A.V., Geraskina L.A. Kardiogennye insul'ty. Nevrologiya, neiropsikhiatriya, psikhosomatika 2009; 1: 23-28.
  34. Fonyakin A.V., Geraskina L.A. Rol' antitromboticheskoi terapii vo vtorichnoi profilaktike ishemicheskogo insul'ta u patsientov s sochetannym porazheniem sosudistykh basseinov. Atmosfera. Nervnye bolezni 2010; 1: 2-5.
  35. Algra A., van Gijn J. Aspirine at any dose above 30 mg offers only modest protection after cerebral ischemia. J Neurol Neurosurg Psychiatry 1996; 60: 197-199.
  36. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration. BMJ 2002; 324: 71-86.
  37. Ardissini D. Optimizing antiplatelet therapy: insight from large outcomes trial. Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 128.
  38. Bhatt D., Fox K., Hacke W. et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-1717.
  39. Baigent C. Should aspirin be used for primary prevention of vascular disease? Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 82.
  40. Boneu B., Destelle G. Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost1996; 76: 939-943.
  41. De Bruijn S.F., Agema W.R., Lammers G.J. et al. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patient of any age with transient ischemic attack or stroke. Stroke 2006; 37: 2531-2534.
  42. Campbell C., Smyth S., Montalescot G., Steinhubl S. Aspirin dose for the prevention of cardiovascular disease: A systematic review. JAMA 2007; 297: 2018-2024.
  43. Challa V. Ateroskleroz sheinykh i vnutricherepnykh sosudov. Sosudistye zabolevaniya golovnogo mozga. Per. s angl. Pod red. akad. RAMN E.I. Guseva, prof. A.B. Gekht. Rukovodstvo dlya vrachei: 6 izd. M: GEOTAR-Media 2007; 21-46.
  44. Christopher P.M., Pharm D., Robert L. et al. FCCP: Aspirin resistance: An Evaluation of Current Evidence and Measurement Methods. Pharmacotherapy 2005; 25: 7: 942-953.
  45. De Cristobal J., Moro M.A., Davalos A. et al. Neuroprotective effect of aspirin by inhibition of glutavate release after permanent focal cerebral ischemia in rats. J Neurochem 2001; 79: 2: 456-459.
  46. Enga K.F., Braekkan S.K., Mathiesen E.B. et al. Impact of coffee consumption on the risk of venous thromboembolism - the Tromso study. Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 121.
  47. de Gaetano J., Crescente M., Cerletti Ch. Environment and lifestyle: can they affect the response to antiplatelet agents? Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 99.
  48. Giles M.F., Rothwell P.M. Risk of stroke early after transient ischemic attack: A systemic review and meta-analysis. Lancet Neurol 2007; 6: 1063-1072.
  49. Gladstone D.J., Bui E., Fang J. et al. Potentially preventable strokes in hight-risk patient with atrial fibrillation who a not adequately anticoagulated. Stroke 2009; 40: 235-240.
  50. Goldstein L.B., Rothwell P.M. Dostizheniya v oblasti profilaktiki i organizatsii okazaniya meditsinskoi pomoshchi pri insul'te v 2009 godu. Rossiiskoe izdanie Stroke 2010; 2/3: 15-22.
  51. Guidelines for management of ischemic stroke and transient ischemic attack 2008.
  52. Gulli G., Khan S., Markus H.S. Stenoz arterii vertebral'no-bazilyarnoi sistemy kak faktor povyshennogo riska razvitiya rannego povtornogo insul'ta v vertebral'no-bazilyarnom basseine i TIA. Rossiiskoe izdanie Stroke 2009; 5/6: 15-22.
  53. Hackam D.G., Spence J.D. Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke. Stroke 2007; 38: 1881-1885.
  54. Halkes P.H., van Gijn J., Kappelle L.J. et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischemia of arterial origin (ESPRIT): randomized controlled trial. Lancet 2006; 367: 9523: 1665-1673.
  55. Hemker H.C., Dieri., Beguin S. Thrombin generation assays: accruing clinical relevane? Curr Opin Hematol 2004; 11: 170-175.
  56. Imberti D., Agnelli G., Moia M. et al. Long term clinical outcomes of cancer associated venous thromboembolism: finding from the master registry. Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 103.
  57. Lenz T.L., Hilleman D.A. Aggrenox: a fixed-dose combination of aspirin and dipyridamole. Ann Pharmacother 2000; 34: 11: 1283-1290.
  58. Liao J., Khalid Z., Scallan C. et al. Noninvasive cardiac monitoring for detecting paroxysmak atrial fibrillation and flutter after acute ischemic stroke: A systematic review. Stroke 2007; 38: 2935-2940.
  59. Luijckx G., de Keyser J.H. The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischemic attack or cerebral infarction: the debate is closed. Ned Tijdschr Geneeskd 2006; 150: 33: 1812-1814.
  60. Mega J.L., Curth R.J.,Chubb A. et al. Cytochrome p-450 polymorphism and response to clopidogrel. N Engl J Med 2009; 360: 354-362.
  61. Meschia J.F. Farmakogenetika i insul't. Rossiiskoe izdanie Stroke 2009; 5/6: 82-87.
  62. Muszbek L., Bereczky Z., Kovacs E. et al. Asririn resistance: myth or reality? Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 98.
  63. Oliveira D.C., Silva R.F., Silva D.J., Lima V.C. Aspirin resistance: fact or fiction? Arq Bras Cardiol 2010; 95: 3: 91-94.
  64. Pettersen A.A.R., Arnesen H., Opstad T.B. et al. Platelet function in clopidogrel-treated patients carryng the 2C19*2 polymorphism. Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 149.
  65. Pettinella C., Romano M., Stuppia L. et al. Cyclooxygenase-1 haplotype C50T/A-842G dose not affect response to aspirin. J Thromb Haemost 2009; 101: 687-690.
  66. Prabhararan S., Wells K.R., Lee V.H. et al. Prevalence and risk factors for aspirin and clopidogrel resistans in cerebrovascular stenting. Am J Neuroradiol 2008; 29: 281-285.
  67. Sacco R.L., Sivenius., Diener H.C. Efficacy of aspirin plus extended- release dipyridamole in preventing recurrent stroke in high-risk populations. Arch Neurol 2005; 62: 3: 403-408.
  68. Sacco R.L., Adams R., Albers G. et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577-617.
  69. Sacco R.L., Diener H., Yusuf S. et al. For the PRoFESS Study Group. Aspirin and extended- release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008; 359: 1238-1251.
  70. Schwarz U.I., Ritchie M.D., Bradford Y. et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008; 358: 999-1008.
  71. Shishlo L., Shamova E., Gorudko I. et al. Characterization of platelet aggregation induced by human cervical carcinoma cells. Pathophysiology of Haemostasis and Trombosis. Abstracts from the 21st International Congress on Thrombosis 2009-2010; 37: Suppl 1: 103.
  72. Simon T., Verstuyft C., Mary-Krause M. et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009; 360: 363-375.
  73. Tammony L. Burns, Pharm. D., Aryan N. Moos et al. Antiplatelet Drug Resistance: Not Ready for Prime Time. Pharmacotherapy 2005; 25: 11: 1621-1628.
  74. The Active Writing Group of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet 2006; 367: 1903-1912.
  75. Toyoda K., Yasaka M., Iwade K. et al. The Bleeding with Antithrombotic Therapy (BAT) Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective multicenter observational study. Stroke 2008; 39: 1740-1745.
  76. Toyoda K., Yasaka M., Nagata K. et al. The Bleeding with Antithrombotic Therapy (BAT) Study Group. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage: the Bleeding with Antithrombotic Therapy (BAT) Retrospective Study. Cerebrovascular Diseases 2009; 27: 151-159.
  77. Toyoda K., Yasaka M., Uchiyama S. et al. Blood pressure levels and bleeding events during antithrombotic therapy: the Bleeding with Antithrombotic Therapy (BAT) Study. Stroke 2010; 41: 1440-1444.
  78. Wakhloo A.K., Deleo M.J., Brown M.M. Dostizheniya v oblasti interventsionnoi neiroradiologii. Rossiiskoe izdanie Stroke 2009; 4: 25-34.
  79. Wu C.M., McLaughil K., Lorenzetti D.L. et al. Early risk of stroke after transient ischemic attack: A systemic review and meta-analysis. Arch Intern Med 2007; 167: 2417-2422.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.